Amyloids—clumps of misfolded proteins found in the brains of people with Alzheimer's disease and other neurodegenerative disorders—are the quintessential bad boys of neurobiology. They're thought to muck up the seamless ...
Apr 3, 2013
1
0
Recent work in mice suggested that the immune system is involved in removing beta-amyloid, the main Alzheimer's-causing substance in the brain. Researchers have now shown for the first time that this may apply in humans.
May 25, 2012
0
0
Alzheimer's disease (AD) is now the sixth leading cause of death among Americans, affecting nearly 1 in 8 people over the age of 65. There is currently no treatment that alters the course of this disease. However, an increasing ...
Apr 10, 2012
0
0
A yet unidentified component of coffee interacts with the beverage's caffeine, which could be a surprising reason why daily coffee intake protects against Alzheimer's disease. A new Alzheimer's mouse study by researchers ...
Jun 21, 2011
2
0
Researchers pinpoint a small RNA that spurs cells to manufacture a particular splice variant of a key neuronal protein, potentially promoting Alzheimer's disease (AD) or other types of neurodegeneration. The study appears ...
May 30, 2011
0
0
Two proteins that are abnormally modified in the brains of patients with Alzheimer disease collude, resulting in ill effects on the crucial energy centers of brain cells, according to new findings published online in Neurobiology ...
May 13, 2011
0
0
(Medical Xpress) -- Higher levels of cell chatter boost amyloid beta in the brain regions that Alzheimer’s hits first, researchers at Washington University School of Medicine in St. Louis report. Amyloid beta is the ...
May 2, 2011
0
0
People with type 2 diabetes are at increased risk of Alzheimer's disease and other adverse cognitive health issues. A new study conducted by Umeå University, Sweden, shows that the reason for the correlation may be that ...
Aug 12, 2024
0
32
Researchers at the University of Alabama at Birmingham have found a potential link between putative retinal gliosis and Alzheimer's disease. The study, published in Investigative Ophthalmology & Visual Science, demonstrates ...
Jun 26, 2024
0
1
An independent panel of US medical experts voted Monday to recommend Eli Lilly's experimental Alzheimer's drug, meaning there could soon be another treatment option available to patients with the devastating brain disorder.
Jun 11, 2024
0
24
